EAACI Congress 2024
BackDermatology 6
Saturday 01 Jun, 12:00 PM -
13:00 PM Valencia, Spain
Poster Zone
Thematic Poster Session
12:00
"In Class Cross-Reactivity" to all tested cephalosporins revealed in a patient with Cefazolin-induced Severe Cutaneous Adverse Drug Reaction
12:00
Development of a Patient Reported Experience Measure (PREM) for interdisciplinary care in systemic diseases with skin manifestations (skin IMIDs)
12:00
Efficacy of lanadelumab on attack frequency and AE-QoL in Serbian patients with hereditary angioedema
12:00
Exploration of the Difference in Child and Adult AD patients
12:00
Gain-of-function mutations of human MRGPRX2 in the Chronic spontaneous urticaria
12:00
Real-world clinical experience with dupilumab use in 33 children with severe atopic dermatitis
12:00
The efficacy in treatment of facial melasma combined with thulium 1927-nm fractional laser and topical H2R antagonist: a split-face, single-blind study
12:00
Trends in surfactant contact allergy in a UK population over a 5-year period
12:00
Unveiling allergic contact dermatitis: a case of healing ointment-induced dermatitis
12:00
Usefulness of skin tests in pointing out a cross-reactivity to Beta-lactam moiety: About a case-series
